Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Glioblastoma Multiforme Therapeutics Market 2018, Forecast to 2023

Choose Licence

 

Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and oligodendrocytes) is called glioma, the commonest forms of brain tumor.? Scope of the Report: This report focuses on the Glioblastoma Multiforme Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Currently unavailable therapies and prognosis for the treatment of GBM is expected to impact the market growth positively through to 2022. Presence of the treatment options which do not increase the overall survival rate in patients such as surgical resection, which is followed by chemotherapy and radiotherapy, is another factor attributing towards the expected growth of this market. Moreover, the fact that glioma stem cells resist conventional treatments also raises urgent need for alternative treatment therapies for glioblastoma multiforme thus driving the market. Increasing R&D in gene therapy and molecular biotechnology for the treatment of CNS associated disorders and cancer is anticipated to fuel the market growth over the forecast period. However, high expenditure involved in research employing genomics based research is a key restraint for market. The worldwide market for Glioblastoma Multiforme Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Arbor Pharmaceuticals Bristol-Myers Squibb Eisai F. Hoffmann-La Roche Merck Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Temozolomide Bevacozumab Carmustine Market Segment by Applications, can be divided into Hospitals Clinics Others There are 15 Chapters to deeply display the global Glioblastoma Multiforme Therapeutics market. Chapter 1, to describe Glioblastoma Multiforme Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Glioblastoma Multiforme Therapeutics, with sales, revenue, and price of Glioblastoma Multiforme Therapeutics, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Glioblastoma Multiforme Therapeutics, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Glioblastoma Multiforme Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Glioblastoma Multiforme Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

 

Table of Contents 1 Market Overview 1.1 Glioblastoma Multiforme Therapeutics Introduction 1.2 Market Analysis by Type 1.2.1 Temozolomide 1.2.2 Bevacozumab 1.2.3 Carmustine 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Arbor Pharmaceuticals 2.1.1 Business Overview 2.1.1.1 Arbor Pharmaceuticals Description 2.1.1.2 Arbor Pharmaceuticals Headquarter, Main Business and Finance Overview 2.1.2 Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Product Introduction 2.1.2.1 Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors 2.1.2.2 Glioblastoma Multiforme Therapeutics Product Information 2.1.3 Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.1 Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.2 Global Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Market Share in 2017 2.2 Bristol-Myers Squibb 2.2.1 Business Overview 2.2.1.1 Bristol-Myers Squibb Description 2.2.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview 2.2.2 Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Product Introduction 2.2.2.1 Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors 2.2.2.2 Glioblastoma Multiforme Therapeutics Product Information 2.2.3 Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.1 Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.2 Global Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Market Share in 2017 2.3 Eisai 2.3.1 Business Overview 2.3.1.1 Eisai Description 2.3.1.2 Eisai Headquarter, Main Business and Finance Overview 2.3.2 Eisai Glioblastoma Multiforme Therapeutics Product Introduction 2.3.2.1 Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors 2.3.2.2 Glioblastoma Multiforme Therapeutics Product Information 2.3.3 Eisai Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.1 Eisai Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.2 Global Eisai Glioblastoma Multiforme Therapeutics Market Share in 2017 2.4 F. Hoffmann-La Roche 2.4.1 Business Overview 2.4.1.1 F. Hoffmann-La Roche Description 2.4.1.2 F. Hoffmann-La Roche Headquarter, Main Business and Finance Overview 2.4.2 F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Product Introduction 2.4.2.1 Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors 2.4.2.2 Glioblastoma Multiforme Therapeutics Product Information 2.4.3 F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.1 F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.2 Global F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Market Share in 2017 2.5 Merck 2.5.1 Business Overview 2.5.1.1 Merck Description 2.5.1.2 Merck Headquarter, Main Business and Finance Overview 2.5.2 Merck Glioblastoma Multiforme Therapeutics Product Introduction 2.5.2.1 Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors 2.5.2.2 Glioblastoma Multiforme Therapeutics Product Information 2.5.3 Merck Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.1 Merck Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.2 Global Merck Glioblastoma Multiforme Therapeutics Market Share in 2017 3 Global Glioblastoma Multiforme Therapeutics Market Competition, by Manufacturer 3.1 Global Glioblastoma Multiforme Therapeutics Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Glioblastoma Multiforme Therapeutics Revenue and Market Share by Manufacturer (2016-2017) 3.3 Global Glioblastoma Multiforme Therapeutics Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Glioblastoma Multiforme Therapeutics Manufacturer Market Share in 2017 3.4.2 Top 5 Glioblastoma Multiforme Therapeutics Manufacturer Market Share in 2017 3.5 Market Competition Trend 4 Global Glioblastoma Multiforme Therapeutics Market Analysis by Regions 4.1 Global Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Regions 4.1.1 Global Glioblastoma Multiforme Therapeutics Sales by Regions (2013-2018) 4.1.2 Global Glioblastoma Multiforme Therapeutics Revenue by Regions (2013-2018) 4.2 North America Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2013-2018) 4.3 Europe Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2013-2018) 4.5 South America Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2013-2018) 5 North America Glioblastoma Multiforme Therapeutics by Countries, Type, Application and Manufacturers 5.1 North America Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Countries 5.1.1 North America Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) 5.1.2 North America Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) 5.1.3 United States Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 5.1.4 Canada Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 5.1.5 Mexico Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 5.2 North America Glioblastoma Multiforme Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017) 5.2.1 North America Glioblastoma Multiforme Therapeutics Sales by Manufacturers (2016-2017) 5.2.2 North America Glioblastoma Multiforme Therapeutics Revenue by Manufacturers (2016-2017) 5.3 North America Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Type (2013-2018) 5.3.1 North America Glioblastoma Multiforme Therapeutics Sales and Sales Share by Type (2013-2018) 5.3.2 North America Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Type (2013-2018) 5.4 North America Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Application (2013-2018) 5.4.1 North America Glioblastoma Multiforme Therapeutics Sales and Sales Share by Application (2013-2018) 5.4.2 North America Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Application (2013-2018) 6 Europe Glioblastoma Multiforme Therapeutics by Countries, Type, Application and Manufacturers 6.1 Europe Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Countries 6.1.1 Europe Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) 6.1.2 Europe Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) 6.1.3 Germany Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 6.1.4 UK Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 6.1.5 France Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 6.1.6 Russia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 6.1.7 Italy Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 6.2 Europe Glioblastoma Multiforme Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017) 6.2.1 Europe Glioblastoma Multiforme Therapeutics Sales by Manufacturers (2016-2017) 6.2.2 Europe Glioblastoma Multiforme Therapeutics Revenue by Manufacturers (2016-2017) 6.3 Europe Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Type (2013-2018) 6.3.1 Europe Glioblastoma Multiforme Therapeutics Sales and Sales Share by Type (2013-2018) 6.3.2 Europe Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Type (2013-2018) 6.4 Europe Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Application (2013-2018) 6.4.1 Europe Glioblastoma Multiforme Therapeutics Sales and Sales Share by Application (2013-2018) 6.4.2 Europe Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Application (2013-2018) 7 Asia-Pacific Glioblastoma Multiforme Therapeutics by Countries, Type, Application and Manufacturers 7.1 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) 7.1.2 Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) 7.1.3 China Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 7.1.4 Japan Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 7.1.5 Korea Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 7.1.6 India Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 7.1.7 Southeast Asia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 7.2 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017) 7.2.1 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales by Manufacturers (2016-2017) 7.2.2 Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue by Manufacturers (2016-2017) 7.3 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Type (2013-2018) 7.3.1 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales and Sales Share by Type (2013-2018) 7.3.2 Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Type (2013-2018) 7.4 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Application (2013-2018) 7.4.1 Asia-Pacific Glioblastoma Multiforme Therapeutics Sales and Sales Share by Application (2013-2018) 7.4.2 Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Application (2013-2018) 8 South America Glioblastoma Multiforme Therapeutics by Countries, Type, Application and Manufacturers 8.1 South America Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Countries 8.1.1 South America Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) 8.1.2 South America Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) 8.1.3 Brazil Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 8.1.4 Argentina Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 8.1.5 Colombia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 8.2 South America Glioblastoma Multiforme Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017) 8.2.1 South America Glioblastoma Multiforme Therapeutics Sales by Manufacturers (2016-2017) 8.2.2 South America Glioblastoma Multiforme Therapeutics Revenue by Manufacturers (2016-2017) 8.3 South America Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Type (2013-2018) 8.3.1 South America Glioblastoma Multiforme Therapeutics Sales and Sales Share by Type (2013-2018) 8.3.2 South America Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Type (2013-2018) 8.4 South America Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Application (2013-2018) 8.4.1 South America Glioblastoma Multiforme Therapeutics Sales and Sales Share by Application (2013-2018) 8.4.2 South America Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Application (2013-2018) 9 Middle East and Africa Glioblastoma Multiforme Therapeutics by Countries, Type, Application and Manufacturers 9.1 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) 9.1.2 Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) 9.1.3 Saudi Arabia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 9.1.4 UAE Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 9.1.5 Egypt Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 9.1.6 Nigeria Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 9.1.7 South Africa Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) 9.2 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017) 9.2.1 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales by Manufacturers (2016-2017) 9.2.2 Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue by Manufacturers (2016-2017) 9.3 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Type (2013-2018) 9.3.1 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales and Sales Share by Type (2013-2018) 9.3.1 Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Type (2013-2018) 9.4 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Application (2013-2018) 9.4.1 Middle East and Africa Glioblastoma Multiforme Therapeutics Sales and Sales Share by Application (2013-2018) 9.4.2 Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue and Revenue Share by Application (2013-2018) 10 Global Glioblastoma Multiforme Therapeutics Market Segment by Type 10.1 Global Glioblastoma Multiforme Therapeutics Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Glioblastoma Multiforme Therapeutics Sales and Market Share by Type (2013-2018) 10.1.2 Global Glioblastoma Multiforme Therapeutics Revenue and Market Share by Type (2013-2018) 10.2 Temozolomide Sales Growth and Price 10.2.1 Global Temozolomide Sales Growth (2013-2018) 10.2.2 Global Temozolomide Price (2013-2018) 10.3 Bevacozumab Sales Growth and Price 10.3.1 Global Bevacozumab Sales Growth (2013-2018) 10.3.2 Global Bevacozumab Price (2013-2018) 10.4 Carmustine Sales Growth and Price 10.4.1 Global Carmustine Sales Growth (2013-2018) 10.4.2 Global Carmustine Price (2013-2018) 11 Global Glioblastoma Multiforme Therapeutics Market Segment by Application 11.1 Global Glioblastoma Multiforme Therapeutics Sales Market Share by Application (2013-2018) 11.2 Hospitals Sales Growth (2013-2018) 11.3 Clinics Sales Growth (2013-2018) 11.4 Others Sales Growth (2013-2018) 12 Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) 12.1 Global Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2018-2023) 12.2 Glioblastoma Multiforme Therapeutics Market Forecast by Regions (2018-2023) 12.2.1 North America Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) 12.2.2 Europe Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) 12.2.3 Asia-Pacific Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) 12.2.4 South America Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) 12.2.5 Middle East and Africa Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) 12.3 Glioblastoma Multiforme Therapeutics Market Forecast by Type (2018-2023) 12.3.1 Global Glioblastoma Multiforme Therapeutics Sales Forecast by Type (2018-2023) 12.3.2 Global Glioblastoma Multiforme Therapeutics Market Share Forecast by Type (2018-2023) 12.4 Glioblastoma Multiforme Therapeutics Market Forecast by Application (2018-2023) 12.4.1 Global Glioblastoma Multiforme Therapeutics Sales Forecast by Application (2018-2023) 12.4.2 Global Glioblastoma Multiforme Therapeutics Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Glioblastoma Multiforme Therapeutics Picture Table Product Specifications of Glioblastoma Multiforme Therapeutics Figure Global Glioblastoma Multiforme Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 ( Million) Figure Global Glioblastoma Multiforme Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales) Figure Global Sales Market Share of Glioblastoma Multiforme Therapeutics by Types in 2017 Figure Temozolomide Picture Table Major Manufacturers of Temozolomide Figure Bevacozumab Picture Table Major Manufacturers of Bevacozumab Figure Carmustine Picture Table Major Manufacturers of Carmustine Figure Glioblastoma Multiforme Therapeutics Sales Market Share by Applications in 2017 Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Figure United States Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Canada Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Germany Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure France Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure UK Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Russia Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Italy Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure China Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Japan Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Korea Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure India Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Glioblastoma Multiforme Therapeutics Revenue (Value) and Growth Rate (2013-2023) Table Arbor Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017) Table Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors Table Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Product Table Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Sales Market Share in 2017 Figure Global Arbor Pharmaceuticals Glioblastoma Multiforme Therapeutics Revenue Market Share in 2017 Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017) Table Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors Table Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Product Table Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Sales Market Share in 2017 Figure Global Bristol-Myers Squibb Glioblastoma Multiforme Therapeutics Revenue Market Share in 2017 Table Eisai Headquarter, Established, Main Business and Finance Overview (2017) Table Eisai Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors Table Eisai Glioblastoma Multiforme Therapeutics Product Table Eisai Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Eisai Glioblastoma Multiforme Therapeutics Sales Market Share in 2017 Figure Global Eisai Glioblastoma Multiforme Therapeutics Revenue Market Share in 2017 Table F. Hoffmann-La Roche Headquarter, Established, Main Business and Finance Overview (2017) Table F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors Table F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Product Table F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Sales Market Share in 2017 Figure Global F. Hoffmann-La Roche Glioblastoma Multiforme Therapeutics Revenue Market Share in 2017 Table Merck Headquarter, Established, Main Business and Finance Overview (2017) Table Merck Glioblastoma Multiforme Therapeutics Production Bases, Sales Regions and Major Competitors Table Merck Glioblastoma Multiforme Therapeutics Product Table Merck Glioblastoma Multiforme Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Merck Glioblastoma Multiforme Therapeutics Sales Market Share in 2017 Figure Global Merck Glioblastoma Multiforme Therapeutics Revenue Market Share in 2017 Table Global Glioblastoma Multiforme Therapeutics Sales by Manufacturer (2016-2017) Figure Global Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2016 Figure Global Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2017 Table Global Glioblastoma Multiforme Therapeutics Revenue by Manufacturer (2016-2017) Figure Global Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2016 Figure Global Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2017 Table Global Glioblastoma Multiforme Therapeutics Price by Manufacturer (2016-2017) Figure Top 3 Glioblastoma Multiforme Therapeutics Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Glioblastoma Multiforme Therapeutics Manufacturer (Revenue) Market Share in 2017 Figure Global Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Global Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Sales by Regions (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Sales Market Share by Regions (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Revenue by Regions (2013-2018) Figure Global Glioblastoma Multiforme Therapeutics Revenue Market Share by Regions in 2013 Figure Global Glioblastoma Multiforme Therapeutics Revenue Market Share by Regions in 2017 Figure North America Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure North America Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Figure Europe Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Europe Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Figure South America Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure South America Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Figure North America Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Sales Market Share by Countries (2013-2018) Figure North America Glioblastoma Multiforme Therapeutics Sales Market Share by Countries in 2013 Figure North America Glioblastoma Multiforme Therapeutics Sales Market Share by Countries in 2017 Table North America Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries (2013-2018) Figure North America Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2013 Figure North America Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2017 Figure United States Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Canada Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Mexico Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Sales by Manufacturer (2016-2017) Figure North America Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2016 Figure North America Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2017 Table North America Glioblastoma Multiforme Therapeutics Revenue by Manufacturer (2016-2017) Figure North America Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2016 Figure North America Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2017 Table North America Glioblastoma Multiforme Therapeutics Sales by Type (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Sales Share by Type (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Revenue by Type (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Revenue Share by Type (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Sales by Application (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Sales Share by Application (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Revenue by Application (2013-2018) Table North America Glioblastoma Multiforme Therapeutics Revenue Share by Application (2013-2018) Figure Europe Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Sales Market Share by Countries (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) Figure Europe Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2016 Figure Europe Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2017 Figure Germany Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure UK Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure France Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Russia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Italy Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Sales by Manufacturer (2016-2017) Figure Europe Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2016 Figure Europe Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2017 Table Europe Glioblastoma Multiforme Therapeutics Revenue by Manufacturer (2016-2017) Figure Europe Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2016 Figure Europe Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2017 Table Europe Glioblastoma Multiforme Therapeutics Sales by Type (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Sales Share by Type (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Revenue by Type (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Revenue Share by Type (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Sales by Application (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Sales Share by Application (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Revenue by Application (2013-2018) Table Europe Glioblastoma Multiforme Therapeutics Revenue Share by Application (2013-2018) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Sales Market Share by Countries 2017 Table Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries 2017 Figure China Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Japan Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Korea Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure India Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Southeast Asia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales by Manufacturer (2016-2017) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2016 Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2017 Table Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue by Manufacturer (2016-2017) Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2016 Figure Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2017 Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales by Type (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales Share by Type (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue by Type (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue Share by Type (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales by Application (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Sales Share by Application (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue by Application (2013-2018) Table Asia-Pacific Glioblastoma Multiforme Therapeutics Revenue Share by Application (2013-2018) Figure South America Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Sales Market Share by Countries (2013-2018) Figure South America Glioblastoma Multiforme Therapeutics Sales Market Share by Countries in 2017 Table South America Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries (2013-2018) Figure South America Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2017 Figure Brazil Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Argentina Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Colombia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Sales by Manufacturer (2016-2017) Figure South America Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2016 Figure South America Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2017 Table South America Glioblastoma Multiforme Therapeutics Revenue by Manufacturer (2016-2017) Figure South America Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2016 Figure South America Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2017 Table South America Glioblastoma Multiforme Therapeutics Sales by Type (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Sales Share by Type (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Revenue by Type (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Revenue Share by Type (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Sales by Application (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Sales Share by Application (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Revenue by Application (2013-2018) Table South America Glioblastoma Multiforme Therapeutics Revenue Share by Application (2013-2018) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue and Growth Rate (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales by Countries (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Sales Market Share by Countries in 2017 Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue by Countries (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2013 Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Market Share by Countries in 2017 Figure Saudi Arabia Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure UAE Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Egypt Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure Nigeria Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Figure South Africa Glioblastoma Multiforme Therapeutics Sales and Growth Rate (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales by Manufacturer (2016-2017) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2016 Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Sales Market Share by Manufacturer in 2017 Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue by Manufacturer (2016-2017) Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2016 Figure Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Market Share by Manufacturer in 2017 Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales by Type (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales Share by Type (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue by Type (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Share by Type (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales by Application (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Sales Share by Application (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue by Application (2013-2018) Table Middle East and Africa Glioblastoma Multiforme Therapeutics Revenue Share by Application (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Sales by Type (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Sales Share by Type (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Revenue by Type (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Revenue Share by Type (2013-2018) Figure Global Temozolomide Sales Growth (2013-2018) Figure Global Temozolomide Price (2013-2018) Figure Global Bevacozumab Sales Growth (2013-2018) Figure Global Bevacozumab Price (2013-2018) Figure Global Carmustine Sales Growth (2013-2018) Figure Global Carmustine Price (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Sales by Application (2013-2018) Table Global Glioblastoma Multiforme Therapeutics Sales Share by Application (2013-2018) Figure Global Hospitals Sales Growth (2013-2018) Figure Global Clinics Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Glioblastoma Multiforme Therapeutics Sales, Revenue and Growth Rate (2018-2023) Table Global Glioblastoma Multiforme Therapeutics Sales Forecast by Regions (2018-2023) Table Global Glioblastoma Multiforme Therapeutics Market Share Forecast by Regions (2018-2023) Figure North America Sales Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) Figure Europe Sales Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) Figure Asia-Pacific Sales Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) Figure South America Sales Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) Figure Middle East and Africa Sales Glioblastoma Multiforme Therapeutics Market Forecast (2018-2023) Table Global Glioblastoma Multiforme Therapeutics Sales Forecast by Type (2018-2023) Table Global Glioblastoma Multiforme Therapeutics Market Share Forecast by Type (2018-2023) Table Global Glioblastoma Multiforme Therapeutics Sales Forecast by Application (2018-2023) Table Global Glioblastoma Multiforme Therapeutics Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Other Reports by GlobalInfoResearch

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Photoresist Market 2018, Forecast to 2023

A photoresist is a light-sensitive material used in several processes, such as photolithography and photoengraving, to form a patterned coating on a surface. This process is crucial in the electronic industry.[1] The process begins by coating a subst...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phosphate Market 2018, Forecast to 2023

A phosphate is chemical derivative of phosphoric acid. The phosphate ion is an inorganic chemical, the conjugate base that can form many different salts. In organic chemistry, a phosphate, or organophosphate, is an ester of phosphoric acid. Of the va...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phenolic Resin Market 2018, Forecast to 2023

Phenolic resins or phenol formaldehyde resins or 2-methoxy-6-methylphenol are synthetic polymers that are obtained by the polymerization of formaldehyde and phenol. These are resistant to acids, water, and organic solvents. These are used especially ...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phenol Derivatives Market 2018, Forecast to 2023

In organic chemistry, phenols, sometimes called phenolics, are a class of chemical compounds consisting of a hydroxyl group (?OH) bonded directly to an aromatic hydrocarbon group. Phenolic compounds are classified as simple phenols or polyphenols bas...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Phase Change Materials (PCM) Market 2018, Forecast to 2023

Phase change materials (PCMs) are substances with a high enthalpy of fusion, also known as latent heat, meaning they can store large quantities of heat energy as they change phase. When melting, they absorb heat and maintain the temperature of the en...

New Pharmaceuticals and Healthcare Reports